Optimal Allocation of COVID-19 Test Kits Among Accredited Testing Centers in the Philippines.

Optimal Allocation of COVID-19 Test Kits Among Accredited Testing Centers in the Philippines.
复制标题

DOI:
10.1007/s41666-020-00081-5
复制
发表时间:
2021-03
影响因子:
5.9
通讯作者:
Mamplata JB
Mamplata JB
中科院分区:
其他
文献类型:
--
作者:
Buhat CAH;Duero JCC;Felix EFO;Rabajante JF;Mamplata JB

文献摘要

参考文献

被引文献

相似文献

检测对于早期发现、隔离和治疗冠状病毒病(新冠肺炎)感染者至关重要。然而,在菲律宾等资源有限的国家,检测试剂盒的供应有限。截至2020年4月11日,全国已有11个检测中心获得卫生部(DOH)的认证进行检测。在本文中,我们使用非线性规划(NLP)来确定在菲律宾经认证的检测中心之间的新冠肺炎检测试剂盒的最优百分比分配,从而使所有感染者都有公平的机会接受检测。模型考虑了测试可达性、直辖市人口密度和测试设施容量的异质性。结果表明,各检测中心的最优配置范围为:热带医学研究所(4.17-6.34%)、圣拉萨罗医院(14.65-24.03%)、菲律宾大学-国立卫生研究院(16.25-44.80%)、菲律宾肺科中心(15.8-26.40%)、碧桂园综合医院医疗中心(0.58-0.76%)、帕西格市医学城(5.96-25.51%)、圣卢克医学中心、昆松市(1.09-6.70%)、比科尔公共卫生实验室(0.06-0.08%)、西维萨亚斯医疗中心(0.71-4.52%)、文森特苏托纪念医疗中心(1.02%-2.61%)和菲律宾南部医疗中心(≈ 0.01%)。我们的结果可以作为当局分发新冠肺炎检测试剂盒的指导。这些也可以用来建议增加检测中心,并适当和公平地利用现有的检测试剂盒,这有助于“平坦”疫情曲线。
Testing is crucial for early detection, isolation, and treatment of coronavirus disease (COVID-19)-infected individuals. However, in resource-constrained countries such as the Philippines, test kits have limited availability. As of 11 April 2020, there are 11 testing centers in the country that have been accredited by the Department of Health (DOH) to conduct testing. In this paper, we use nonlinear programming (NLP) to determine the optimal percentage allocation of COVID-19 test kits among accredited testing centers in the Philippines that gives an equitable chance to all infected individuals to be tested. Heterogeneity in testing accessibility, population density of municipalities, and the capacity of testing facilities are included in the model. Our results show that the range of optimal allocation per testing center are as follows: Research Institute for Tropical Medicine (4.17–6.34%), San Lazaro Hospital (14.65–24.03%), University of the Philippines-National Institutes of Health (16.25–44.80%), Lung Center of the Philippines (15.8–26.40%), Baguio General Hospital Medical Center (0.58–0.76%), The Medical City, Pasig City (5.96–25.51%), St. Luke’s Medical Center, Quezon City (1.09–6.70%), Bicol Public Health Laboratory (0.06–0.08%), Western Visayas Medical Center (0.71–4.52%), Vicente Sotto Memorial Medical Center (1.02–2.61%), and Southern Philippines Medical Center (≈ 0.01%). Our results can serve as a guide to the authorities in distributing the COVID-19 test kits. These can also be used for proposing additional testing centers and utilizing the available test kits properly and equitably, which helps in “flattening” the epidemic curve.
DOI: 10.1126/science.abb5793
发表时间: 2020-05-22
期刊: SCIENCE
影响因子: 56.9
作者:
Kissler, Stephen M.;Tedijanto, Christine;Lipsitch, Marc
通讯作者: Lipsitch, Marc
DOI: 10.3201/eid2501.171901
发表时间: 2019-01-01
影响因子: 11.8
作者:
Delamater, Paul L.;Street, Erica J.;Jacobsen, Kathryn H.
通讯作者: Jacobsen, Kathryn H.
DOI: 10.1371/journal.pmed.0020050
发表时间: 2005-02-01
期刊: PLOS MEDICINE
影响因子: 15.8
作者:
Wilson, DP;Blower, SM
通讯作者: Blower, SM
DOI: 10.1136/postgradmedj-2020-137738
发表时间: 2020-07
影响因子: 5.1
作者:
Choi, Jun Yong
通讯作者: Choi, Jun Yong
DOI: 10.1007/s11538-020-00726-x
发表时间: 2020-04-08
影响因子: 3.5
作者:
Eubank, S.;Eckstrand, I;Barrett, C. L.
通讯作者: Barrett, C. L.